Document Detail


Restless leg syndrome associated with olanzapine: a case series.
MedLine Citation:
PMID:  20406161     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Restless leg syndrome (RLS) is a common disorder associated with significant distress. We report three cases of drug induced RLS caused by olanzapine. In each case, RLS commenced after initiation of treatment with olanzapine and resolved after ceasing olanzapine. All three patients were subsequently treated with other atypical antipsychotics, risperidone, quetiapine or aripiprazole, without re-emergence of RLS. RLS is associated with central dopaminergic dysfunction. Dopamine agonists and L-dopa reduce the symptoms of RLS, and some agents that block the dopaminergic system aggravate RLS. Greater awareness of potential causes of RLS, and its differentiation from akathisia and illness related agitation might help in reducing the distress associated with it and improving patient compliance.
Authors:
Shilpa Aggarwal; Seetald Dodd; Michael Berk
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Current drug safety     Volume:  5     ISSN:  1574-8863     ISO Abbreviation:  Curr Drug Saf     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-21     Completed Date:  2010-12-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101270895     Medline TA:  Curr Drug Saf     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  129-31     Citation Subset:  IM    
Affiliation:
Department of Clinical and Biomedical Sciences, University of Melbourne, Geelong, Victoria, Australia. shilpazq@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / adverse effects,  therapeutic use
Benzodiazepines / adverse effects*
Dopamine Agents / therapeutic use
Female
Humans
Male
Middle Aged
Restless Legs Syndrome / chemically induced*,  diagnosis*,  drug therapy
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Dopamine Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are...
Next Document:  Paliperidone use in the elderly.